Nalaganje...
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
Peptide vaccines are capable of eliciting immune responses targeting tumor-associated antigens such as the Wilms’ Tumor 1 (WT1) antigen, often overexpressed in myeloid malignancies. Here, we assessed the safety, tolerability, and immunogenicity of a polyvalent WT1 peptide vaccine. Individuals with W...
Shranjeno v:
| izdano v: | Am J Hematol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4617516/ https://ncbi.nlm.nih.gov/pubmed/25802083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24014 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|